Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000227744 | SCV000290282 | benign | Adams-Oliver syndrome 5 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001171098 | SCV000319448 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-02-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000418388 | SCV000530492 | benign | not specified | 2018-01-24 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000418388 | SCV000707298 | benign | not specified | 2017-04-06 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000660170 | SCV000782164 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001171098 | SCV001333776 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-11-29 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000227744 | SCV002554337 | benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270048 | SCV002554339 | benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001579392 | SCV002564087 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | NOTCH1: BP4, BP7, BS1, BS2 |
ARUP Laboratories, |
RCV001579392 | SCV003799684 | benign | not provided | 2023-11-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000418388 | SCV004029576 | benign | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001579392 | SCV005228670 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001579392 | SCV001807061 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001579392 | SCV001971100 | likely benign | not provided | no assertion criteria provided | clinical testing |